As we leave the raising behind and start focusing on the...

As we leave the raising behind and start focusing on the exciting stuff BCT will be doing going forward, I thought it would be good to start a clean thread.

For me the next few months will be all about:

1- get a feel for how BCT will gradually increase output to meet Labcon's orders. I think the Sep quarter was an adjustment one as they changed schedule and got set for the new order schedule ( as we saw with the first order in Dec last year).
2- customer conversion: BCT is talking to 50plus parties and the new Labcon contract should help speed up discussions and lead to new orders in the next few quarters.
3- progress on the high temp chip development, which will be a game changer.
4- more colour on market opportunities and the size of those markets as we are just scratching the surface with biobanking.

The potential here is phenomenal and management just need to keep delivering as they have in the past 18 months. With a solid Balance Sheet that can take them to positive FCF without assuming orders from any of the 50parties they are talking to.. well, the upside is tremendous.